Sarina Tanimoto, M.D., M.B.A., serves as the Chief Medical Officer at ARS Pharmaceuticals Inc., a role in which she leverages her extensive experience in the pharmaceutical and healthcare sectors. Dr. Tanimoto earned her medical degree from the University of California, San Francisco, and her MBA from the Wharton School of the University of Pennsylvania. Her career spans significant roles in both clinical practice and pharmaceutical development, demonstrating her unique ability to bridge the gap between medical science and business strategy. Before joining ARS Pharmaceuticals, Dr. Tanimoto held several key positions that shaped her expertise. She previously served as a medical director at a leading pharmaceutical company, where she was instrumental in the development and launch of several high-impact drugs. Her work in this capacity earned her recognition for her innovative approach to clinical trials and patient-centric drug development. At ARS Pharmaceuticals, Dr. Tanimoto is responsible for overseeing the clinical development and medical affairs of the company's product portfolio. Her strategic vision and leadership are pivotal in advancing the company's mission to deliver life-changing therapies to patients. Dr. Tanimoto's achievements extend beyond her corporate roles; she is also an active member of several professional medical associations and frequently contributes to scholarly journals. Her dedication to advancing medical knowledge and improving patient outcomes is evident in her ongoing commitment to research and education. As Chief Medical Officer at ARS Pharmaceuticals, she continues to drive the company forward, ensuring that its scientific endeavors align with the highest standards of medical excellence and patient care.